Article

Pilot trial for toric correction with light-adjustable lens yields promising early results

Early experience from a pilot study shows that spherocylindrical error after cataract surgery can be corrected with a proprietary light-adjustable IOL (LAL, Calhoun Vision) to improve uncorrected visual acuity, said Arturo S. Chayet, MD.

Early experience from a pilot study shows that spherocylindrical error after cataract surgerycan be corrected with a proprietary light-adjustable lens (LAL, Calhoun Vision) to improveuncorrected visual acuity, said Arturo S. Chayet, MD.

Dr. Chayet, medical director, Codet Laser Vision Institute, Tijuana, Mexico, presented resultsfrom the first six patients who underwent small-incision surgery and implantation of the lensfollowed by treatment for residual spherocylindrical error. All patients had at least 2 to 3weeks of post-adjustment follow-up.

Mean cylinder prior to adjustment was –1.37 D and it was reduced to a mean of –0.50 D. The meanvectorial cylinder adjustment was –0.87 D.

Post-adjustment UCVA was improved compared with the pre-adjustment level in all eyes and was20/25 or better. No eyes lost BCVA. Topographic evaluations showed no change in the cornealmaps while wavefront aberrometry illustrated the reduction of astigmatism.

"There are many potential advantages of toric adjustment with the [lens]," Dr. Chayet said. "Itoffers a precise method for correcting sphere and cylinder while allowing surgeons to maintaintheir same technique with respect to incision location and IOL placement. In addition, thespatial profile it can be written along with multifocal corrections.

"With available technology, it is possible to correct up to 2.5 D of cylinder at the spectacleplane," he concluded. "The next step will be to refine the nomograms to achieve higher levelsof correction."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.